Is Teladoc Stock a Good Investment?
Teladoc Investment Advice | TDOC |
- Examine Teladoc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Teladoc's leadership team and their track record. Good management can help Teladoc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Technology space and any emerging trends that could impact Teladoc's business and its evolving consumer preferences.
- Compare Teladoc's performance and market position to its competitors. Analyze how Teladoc is positioned in terms of product offerings, innovation, and market share.
- Check if Teladoc pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Teladoc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Teladoc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Teladoc is a good investment.
Sell | Buy |
Buy
Market Performance | Good | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Teladoc Stock
Researching Teladoc's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 77.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teladoc recorded a loss per share of 5.78. The entity had not issued any dividends in recent years.
To determine if Teladoc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Teladoc's research are outlined below:
| Teladoc appears to be risky and price may revert if volatility continues | |
| Teladoc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.6 B. Net Loss for the year was (220.37 M) with profit before overhead, payroll, taxes, and interest of 1.66 B. | |
| Over 77.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Teladoc Health Inc Stock Price Down 2.75 percent on Nov 26 |
Teladoc Quarterly Gross Profit |
|
Teladoc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Teladoc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Teladoc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Teladoc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Teladoc's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-20 | 2023-12-31 | -0.21 | -0.17 | 0.04 | 19 | ||
2020-04-29 | 2020-03-31 | -0.36 | -0.4 | -0.04 | 11 | ||
2017-05-08 | 2017-03-31 | -0.34 | -0.3 | 0.04 | 11 | ||
2017-03-01 | 2016-12-31 | -0.35 | -0.29 | 0.06 | 17 | ||
2024-07-31 | 2024-06-30 | -0.35 | -0.28 | 0.07 | 20 | ||
2020-02-26 | 2019-12-31 | -0.33 | -0.26 | 0.07 | 21 | ||
2018-05-01 | 2018-03-31 | -0.43 | -0.36 | 0.07 | 16 | ||
2023-04-26 | 2023-03-31 | -0.5 | -0.42 | 0.08 | 16 |
Know Teladoc's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Teladoc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teladoc backward and forwards among themselves. Teladoc's institutional investor refers to the entity that pools money to purchase Teladoc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Voloridge Investment Management, Llc | 2024-09-30 | 2.4 M | Susquehanna International Group, Llp | 2024-06-30 | 2.1 M | Barclays Plc | 2024-06-30 | 2.1 M | Charles Schwab Investment Management Inc | 2024-09-30 | 2.1 M | Assenagon Asset Management Sa | 2024-09-30 | 1.7 M | Qube Research & Technologies | 2024-06-30 | 1.7 M | Norges Bank | 2024-06-30 | 1.5 M | Northern Trust Corp | 2024-09-30 | 1.5 M | Ubs Group Ag | 2024-06-30 | 1.5 M | Blackrock Inc | 2024-06-30 | 21.6 M | Vanguard Group Inc | 2024-09-30 | 17.4 M |
Teladoc's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.97 B.Market Cap |
|
Teladoc's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.13) | (0.14) | |
| Return On Capital Employed | (0.06) | (0.06) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.09) | (0.10) |
Determining Teladoc's profitability involves analyzing its financial statements and using various financial metrics to determine if Teladoc is a good buy. For example, gross profit margin measures Teladoc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Teladoc's profitability and make more informed investment decisions.
Teladoc's Earnings Breakdown by Geography
Please note, the presentation of Teladoc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teladoc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teladoc's management manipulating its earnings.
Evaluate Teladoc's management efficiency
Teladoc has return on total asset (ROA) of (0.0313) % which means that it has lost $0.0313 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5165) %, meaning that it created substantial loss on money invested by shareholders. Teladoc's management efficiency ratios could be used to measure how well Teladoc manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2024, Return On Tangible Assets is expected to decline to -0.14. The current year's Return On Capital Employed is expected to grow to -0.06. At present, Teladoc's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 84.3 M, whereas Net Tangible Assets are projected to grow to (475.5 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.34 | 26.40 | |
| Tangible Book Value Per Share | (2.62) | (2.49) | |
| Enterprise Value Over EBITDA | 25.74 | 27.02 | |
| Price Book Value Ratio | 1.50 | 1.43 | |
| Enterprise Value Multiple | 25.74 | 27.02 | |
| Price Fair Value | 1.50 | 1.43 | |
| Enterprise Value | 4 B | 5.9 B |
The management team at Teladoc has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 0.9 |
Basic technical analysis of Teladoc Stock
As of the 28th of November, Teladoc has the Coefficient Of Variation of 534.97, risk adjusted performance of 0.1515, and Semi Deviation of 2.77. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teladoc, as well as the relationship between them.Teladoc's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teladoc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teladoc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Teladoc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Teladoc's Outstanding Corporate Bonds
Teladoc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teladoc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teladoc bonds can be classified according to their maturity, which is the date when Teladoc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Teladoc's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Teladoc's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1515 | |||
| Market Risk Adjusted Performance | 0.4207 | |||
| Mean Deviation | 3.19 | |||
| Semi Deviation | 2.77 | |||
| Downside Deviation | 3.19 | |||
| Coefficient Of Variation | 534.97 | |||
| Standard Deviation | 4.33 | |||
| Variance | 18.71 | |||
| Information Ratio | 0.1579 | |||
| Jensen Alpha | 0.5743 | |||
| Total Risk Alpha | 0.1473 | |||
| Sortino Ratio | 0.2144 | |||
| Treynor Ratio | 0.4107 | |||
| Maximum Drawdown | 20.96 | |||
| Value At Risk | (4.68) | |||
| Potential Upside | 8.51 | |||
| Downside Variance | 10.16 | |||
| Semi Variance | 7.65 | |||
| Expected Short fall | (3.80) | |||
| Skewness | 1.11 | |||
| Kurtosis | 1.9 |
| Risk Adjusted Performance | 0.1515 | |||
| Market Risk Adjusted Performance | 0.4207 | |||
| Mean Deviation | 3.19 | |||
| Semi Deviation | 2.77 | |||
| Downside Deviation | 3.19 | |||
| Coefficient Of Variation | 534.97 | |||
| Standard Deviation | 4.33 | |||
| Variance | 18.71 | |||
| Information Ratio | 0.1579 | |||
| Jensen Alpha | 0.5743 | |||
| Total Risk Alpha | 0.1473 | |||
| Sortino Ratio | 0.2144 | |||
| Treynor Ratio | 0.4107 | |||
| Maximum Drawdown | 20.96 | |||
| Value At Risk | (4.68) | |||
| Potential Upside | 8.51 | |||
| Downside Variance | 10.16 | |||
| Semi Variance | 7.65 | |||
| Expected Short fall | (3.80) | |||
| Skewness | 1.11 | |||
| Kurtosis | 1.9 |
Consider Teladoc's intraday indicators
Teladoc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teladoc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Teladoc Corporate Filings
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Teladoc Stock media impact
Far too much social signal, news, headlines, and media speculation about Teladoc that are available to investors today. That information is available publicly through Teladoc media outlets and privately through word of mouth or via Teladoc internal channels. However, regardless of the origin, that massive amount of Teladoc data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teladoc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teladoc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teladoc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teladoc alpha.
Teladoc Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Teladoc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Teladoc Historical Investor Sentiment
Investor biases related to Teladoc's public news can be used to forecast risks associated with an investment in Teladoc. The trend in average sentiment can be used to explain how an investor holding Teladoc can time the market purely based on public headlines and social activities around Teladoc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Teladoc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Teladoc and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Teladoc news discussions. The higher the estimate score, the more favorable the investor's outlook on Teladoc.
Teladoc Corporate Directors
| Sandra Fenwick | Independent Director | Profile | |
| Christopher Bischoff | Independent Director | Profile | |
| David Shedlarz | Independent Director | Profile | |
| William Frist | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.78) | Revenue Per Share 15.333 | Quarterly Revenue Growth (0.03) | Return On Assets (0.03) | Return On Equity (0.52) |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Teladoc's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.